The cfMeDIP-seq approach has been used by Nassiri et al. to detect CNS tumor plasma methylomes that allow for many brain tumor types to be distinguished with high accuracy including IDH mutant gliomas, IDH wildtype gliomas, meningiomas, hemangiopericytomas, and low grade glioneuronal tumors [68]. This evidence concerns the gene IDH1 and glioma.